Skip to main content
. 2021 Oct 27;13(10):1405–1416. doi: 10.4254/wjh.v13.i10.1405

Table 1.

Descriptive categorical data for live-donor liver transplant recipients with biliary complications

Variable

n (%)
Indication of liver transplantation HCV 21 (84)
HBV 1 (4)
Combined HCV and HBV 1 (4)
Hepatocellular carcinoma 2 (8)
Donors’ gender Male 17 (68)
Female 8 (32)
Recipients’ gender Male 19 (76)
Female 6 (24)
Immunosuppressant Tacrolimus 22 (88)
Cyclosporine 3 (12)
Biliary leakage - 7 (28)
+ 18 (72)
Need of pigtail catheter for biloma (total = 18) - 15 (83.3)
+ 3 (16.6)
Biliary infection - 0 (0)
+ 25 (100)
Frequency of biliary infection (total = 25) 1-2 Episodes 16 (64)
≥ 3 Episodes 9 (36)
Biliary stricture - 5 (20)
+ 20 (80)
Frequency of biliary stricture (total = 20) 1-2 Episodes 13 (65)
≥ 3 Episodes 7 (28)
Need for ERCP - 5 (20)
+ 20 (80)
Frequency of ERCP 1-2 ERCP 13 (65)
≥ 3 ERCP 7 (28)
Need for PTC - 22 (88)
+ 3 (12)
Frequency of PTC 1 PTC 2 (66.6)
2 PTC 1 (33.3)
Surgical intervention for stricture - 19 (95)
+ 1 (5)
Admission related to biliary complications - 0 (0)
+ 25 (100)
Early biliary infection (total = 25) - 2 (8)
+ 23 (92)
Early biliary stricture (total = 20) - 17 (68)
+ 8 (32)

Data presented in number (n) and percentage (%). ERCP: Endoscopic retrograde cholangiopancreatography; HBV: Hepatitis B virus; HCV: Hepatitis C virus; PTC: Percutaneous transhepatic cholangiography.